Ann: Converting Note & Non-Renounceable Entitlement Offer, page-18

Thanks @Jezzy for clarity. The study design appears to have been flawed and by the time the drop another few million and a year on that who knows what else will be in the market. The landscape has changed since meb started out with comirbidity and multiple diagnosis - making a diagnosis of one almost obsolete. At the other end if things I worry about the Khouri group going quiet. The Khouri group don’t go quiet.